An innovative fertility technology developed at Tel Aviv University is revolutionizing in vitro fertilization, offering hope to struggling couples. The method has shown a significant increase in success rates, nearly doubling the chances of pregnancy. Developed by Natan T. Shaked, the technology focuses on selecting high-quality sperm cells, leading to improved fertilization and increased chances of a healthy pregnancy and birth. The findings have been published in leading scientific journals and are currently being tested in clinical trials across multiple hospitals in Israel and internationally. The technology is being promoted through QART Medical, a startup founded by Shaked and Alon Shalev, which aims to bring this innovation to hospitals worldwide. The company is now focusing on automated sperm selection to further improve the precision and success rates of fertility treatments. With early success stories of couples finally achieving their dream of parenthood, the technology is poised to reshape the future of fertility treatments and improve the outcomes for families struggling with infertility. The next step for QART Medical is global expansion, with plans to introduce the technology in more countries in the near future. Shaked is confident that this technology will not only increase the likelihood of pregnancy but also improve the health of babies born through IVF, making it a game changer for fertility medicine.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
